SCHEMBL21396080

SCHEMBL21396080

N#Cc1ccc(-c2ccc3c(c2)C(c2ccccc2)(c2ccccc2)c2cc(-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)ccc2-3)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.48
▸ ABCG2 Q9UNQ0 13/20 0.46
▸ ABCB1 P08183 9/20 0.46
▸ GABRA1 P14867 1/20 0.44
▸ GABRG2 P18507 1/20 0.44
▸ GABRB3 P28472 1/20 0.44
▸ GABRA5 P31644 1/20 0.44
▸ GABRA3 P34903 1/20 0.44
▸ ABCC1 P33527 4/20 0.41
▸ MYC P01106 1/20 0.41
▸ ALDH1A3 P47895 1/20 0.41
▸ PGR P06401 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21922612 0.99 PDK2 (0.47) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21396081 0.99 PDK2 (0.47) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21922603 0.96 PDK2 (0.45) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21658473 0.96 PDK2 (0.45) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21922819 0.96 PDK2 (0.45) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL23937356 0.96 PDK2 (0.44) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21658475 0.96 PDK2 (0.44) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21922811 0.95 ABCG2 (0.50) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL20691372 0.95 ABCG2 (0.50) PDK2ABCG2ABCB1GABRA1GABRG2
SCHEMBL21922598 0.94 ABCG2 (0.49) PDK2ABCG2ABCB1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same LG CHEM, LTD. (KR) 2023-01-03 — — US disclosed
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-09-30 — — US disclosed
US-20210210694-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2021-07-08 — — US disclosed
US-10950801-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2021-03-16 — — US disclosed
EP-3754734-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2020-12-23 — — EP disclosed
US-20200287142-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM LTD. (KR) 2020-09-10 — — US disclosed
EP-3667749-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2020-06-17 — — EP disclosed
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-04-30 — — US disclosed
WO-2020022771-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2020-01-30 — — WO disclosed
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE AOC2, RUVBL2, RUVBL1 PDK2 3314/4885ABCG2 3953/4885ABCB1 3750/4885
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 PDK2 622/4885ABCG2 2985/4885ABCB1 2827/4885
US-11542237-B2 Fluorene derivative and organic light emitting device comprising same CRY1, CRY2, LEF1 PDK2 2091/4885ABCG2 3152/4885ABCB1 1152/4885
US-20200131138-A1 FLUORENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, LEF1 PDK2 2091/4885ABCG2 3152/4885ABCB1 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback